These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9774949)

  • 1. Impact of radioimmunoscintigraphy on the management of colorectal and ovarian cancer patients: a retrospective study.
    Blend MJ; Bhadkamkar VA
    Cancer Invest; 1998; 16(7):431-41. PubMed ID: 9774949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report.
    Method MW; Serafini AN; Averette HE; Rodriguez M; Penalver MA; Sevin BU
    Cancer; 1996 Jun; 77(11):2286-93. PubMed ID: 8635097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New methods for the staging of colorectal cancer using noninvasive techniques.
    Blend MJ; Abdel-Nabi H
    Semin Surg Oncol; 1996; 12(4):253-63. PubMed ID: 8829284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates.
    Maguire RT; Pascucci VL; Maroli AN; Gulfo JV
    Cancer; 1993 Dec; 72(11 Suppl):3453-62. PubMed ID: 8242578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoscintigraphy in patients with ovarian cancer.
    Kalofonos HP; Karamouzis MV; Epenetos AA
    Acta Oncol; 2001; 40(5):549-57. PubMed ID: 11669325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
    Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW
    Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies in ovarian and prostate cancer.
    Neal CE; Swenson LC; Fanning J; Texter JH
    Semin Nucl Med; 1993 Apr; 23(2):114-26. PubMed ID: 8511599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
    Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
    Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer.
    Neal CE; Meis LC
    Semin Nucl Med; 1994 Oct; 24(4):272-85. PubMed ID: 7817200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
    Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
    Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic evaluation of 111In and 99mTc radiolabelled monoclonal antibodies in ovarian and colorectal cancer: correlations with surgery.
    Granowska M; Mather SJ; Britton KE
    Int J Rad Appl Instrum B; 1991; 18(4):413-24. PubMed ID: 1864730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methodology and clinical usefulness of radioimmunoimaging using radiolabeled monoclonal antibodies].
    Endo K; Watanabe N
    Nihon Rinsho; 1996 Jun; 54(6):1604-9. PubMed ID: 8691616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of indium-111-labeled monoclonal antibody imaging in colorectal cancer patients.
    Abdel-Nabi H; Doerr RJ
    Semin Nucl Med; 1993 Apr; 23(2):99-113. PubMed ID: 8511606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indium-labeled anti-colorectal carcinoma monoclonal antibody accumulation in non-tumored tissue in patients with colorectal carcinoma.
    Abdel-Nabi HH; Chan HW; Doerr RJ
    J Nucl Med; 1990 Dec; 31(12):1975-9. PubMed ID: 2266396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioimmunoscintigraphy of colorectal tumors: state of the art (2)].
    Barzen G; Felix R
    Aktuelle Radiol; 1992 Sep; 2(5):262-70. PubMed ID: 1420384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunodetection of colorectal cancer metastases with 131I-labeled monoclonal antibody B72.3: a pilot study to determine efficacy of detection and pharmacokinetics.
    Stern H; Reilly R; Gallinger S; Kirsh J; DeAngelis C; Papa M; Hay K; Polihronis J; Schmoker B
    Cancer Invest; 1993; 11(2):129-34. PubMed ID: 8462013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
    Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoscintigraphy using monoclonal antibodies before second-look surgery in patients suffering from ovarian cancer.
    Pateisky N; Philipp K; Sevelda P; Skodler WD; Enzelsberger H; Hamilton G; Burchell J; Schatten C
    Gynecol Obstet Invest; 1987; 24(3):211-6. PubMed ID: 3692333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoscintigraphy of recurrent colorectal carcinoma using 111In-labelled murine monoclonal antibody B72.3: a comparison with contrast-enhanced computed tomography.
    Kmiot WA; Stonelake P; Sagar G; Donovan IA; Neoptolemos JP; Notghi A; Harding LK
    Nucl Med Commun; 1993 Sep; 14(9):788-91. PubMed ID: 8233244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoscintigraphy of colorectal carcinoma using technetium-99m-labeled, totally human monoclonal antibody 88BV59H21-2.
    Gulec SA; Serafini AN; Moffat FL; Vargas-Cuba RD; Sfakianakis GN; Franceschi D; Crichton VZ; Subramanian R; Klein JL; De Jager RL
    Cancer Res; 1995 Dec; 55(23 Suppl):5774s-5776s. PubMed ID: 7493345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.